Tadalafil and organic nitrates should not be used together under current U.S. labeling. The contraindication applies to regular or intermittent nitrate use because tadalafil can potentiate the hypotensive effect of nitrates and cause blood pressure to fall to an unsafe level.
The interaction reflects overlapping nitric oxide and cyclic GMP signaling. Organic nitrates increase vasodilatory signaling through the NO-cGMP pathway, while tadalafil inhibits PDE5, the enzyme responsible for breaking down cGMP; combining those effects can amplify systemic vasodilation.
Tadalafil's long persistence makes timing clinically important, but the label does not convert the interaction into a consumer-directed waiting-period rule. A dedicated nitroglycerin study evaluated the interaction through 96 hours, and the label's 48-hour language applies only to a life-threatening situation in which nitrate administration is medically necessary under close medical supervision.
The nitrate interaction is one of tadalafil's formal contraindicated drug combinations. It is not classified merely as an interaction to monitor or a precaution to manage with routine dose spacing.
Current labeling applies the contraindication broadly to any form of organic nitrate, whether used regularly or intermittently. The underlying concern is excessive blood-pressure lowering from overlapping vasodilatory signaling.
This page focuses specifically on the nitrate mechanism and timing evidence; the complete list of formal exclusions remains on the tadalafil contraindications page.
| Question | Current label answer |
|---|---|
| Tadalafil + organic nitrate | Contraindicated |
| Regular nitrate use | Contraindicated |
| Intermittent nitrate use | Contraindicated |
| Primary concern | Potentiation of nitrate-induced hypotension |
| Routine management by self-directed dose spacing | Not supported as a substitute for the contraindication |
Nitric oxide stimulates formation of cyclic guanosine monophosphate, or cGMP, in smooth muscle. Increased cGMP promotes smooth-muscle relaxation and vasodilation.
Tadalafil inhibits phosphodiesterase type 5, or PDE5, which increases the amount of cGMP available in tissues where PDE5 is active. Organic nitrates add nitric oxide-driven signaling to the same broader pathway, so the combination can produce a substantially stronger vasodilatory effect than either exposure would suggest in isolation.
The clinically important consequence is hypotension rather than simply an increase in tadalafil concentration. This makes the nitrate interaction primarily pharmacodynamic, unlike CYP3A4 interactions that change tadalafil exposure.
| Step | Effect |
|---|---|
| Organic nitrate | Increases nitric oxide-related signaling |
| Nitric oxide | Promotes cGMP formation |
| cGMP | Relaxes vascular smooth muscle |
| Tadalafil | Inhibits PDE5-mediated cGMP breakdown |
| Combined effect | Potentially excessive vasodilation and blood-pressure reduction |
The nitrate contraindication is not based on nitrates raising tadalafil blood levels or tadalafil blocking nitrate metabolism. The major concern is that both exposures amplify a shared vasodilatory signaling system.
That distinction explains why this interaction is treated differently from a CYP3A4 inhibitor, which can increase tadalafil AUC or Cmax by slowing metabolism. A pharmacodynamic combination can be dangerous even when neither drug meaningfully changes the other's plasma concentration.
The broader interaction taxonomy is summarized on the tadalafil drug-interactions hub.
| Interaction type | Tadalafil + nitrates |
|---|---|
| Primary category | Pharmacodynamic |
| Main variable affected | Vasodilatory / blood-pressure effect |
| Requires increased tadalafil concentration? | No |
| Regulatory outcome | Contraindicated |
Current CIALIS patient information gives concrete examples because patients may not recognize a medicine as a nitrate from its brand name or dosage form. It specifically names nitroglycerin, isosorbide dinitrate and isosorbide mononitrate.
Nitroglycerin can be supplied in several forms, including tablets, sprays, ointments, pastes and patches. The contraindication is therefore not limited to one route of administration or to a tablet taken every day.
If the identity of a medicine is uncertain, current patient information advises checking with a healthcare professional or pharmacist rather than assuming it is compatible with tadalafil.
| Example | Current CIALIS patient-information context |
|---|---|
| Nitroglycerin | Organic nitrate; multiple dosage forms are mentioned |
| Isosorbide dinitrate | Organic nitrate |
| Isosorbide mononitrate | Organic nitrate |
CIALIS patient information specifically notes nitroglycerin in tablets, sprays, ointments, pastes and patches. That breadth matters because a person may incorrectly assume the interaction applies only to sublingual tablets used for an acute angina episode.
The prescribing information instead contraindicates any form of organic nitrate used regularly or intermittently. Route or frequency does not turn routine combined use into an acceptable interaction.
The exact medication list should therefore be reviewed by active ingredient rather than by dosage form alone.
| Nitroglycerin form mentioned in patient information | Excluded from the nitrate warning? |
|---|---|
| Tablet | No |
| Spray | No |
| Ointment / paste | No |
| Patch | No |
Current CIALIS patient information warns that some recreational products known as 'poppers' contain nitrates or nitrites, including amyl nitrite and butyl nitrite. They are specifically included in the patient-facing do-not-use guidance.
This is clinically important because a recreational substance may not be perceived as a medication and therefore may be omitted from a medication history. The interaction concern remains excessive vasodilation and unsafe blood-pressure lowering.
The presence of a recreational product rather than a prescription bottle does not make the nitrate-related warning irrelevant.
| Substance example | Patient-label context |
|---|---|
| Amyl nitrite | Mentioned in connection with recreational 'poppers' |
| Butyl nitrite | Mentioned in connection with recreational 'poppers' |
| Reason for inclusion | Potential nitrate/nitrite-related interaction with tadalafil |
Current CIALIS clinical pharmacology includes a dedicated study designed to determine when the blood-pressure interaction with nitroglycerin was no longer apparent after tadalafil exposure. It was a double-blind, placebo-controlled, crossover study involving 150 men aged at least 40 years, including some participants with diabetes or controlled hypertension.
Participants received tadalafil 20 mg once daily or matching placebo for 7 days. After the final tadalafil or placebo dose, a single 0.4 mg dose of sublingual nitroglycerin was administered at prespecified timepoints.
The study design is important because its timing results come from a specific controlled regimen rather than from a theoretical calculation based only on tadalafil's half-life.
| Study feature | Design |
|---|---|
| Design | Double-blind, placebo-controlled, crossover |
| Participants | 150 men aged ≥40 years |
| Tadalafil regimen | 20 mg daily for 7 days |
| Comparator | Matching placebo |
| Nitroglycerin challenge | 0.4 mg sublingual NTG |
| Post-tadalafil timepoints | 2, 4, 8, 24, 48, 72 and 96 hours |
A significant interaction between tadalafil and nitroglycerin was observed at each tested timepoint through and including 24 hours after the last tadalafil dose. This provides direct clinical pharmacology evidence that the interaction can persist well beyond the immediate dosing period.
At 48 hours, the interaction was no longer observed by most hemodynamic measures, although a few more tadalafil-treated participants than placebo-treated participants still experienced greater blood-pressure lowering. After 48 hours, the interaction was not detectable in the study.
These findings support the label's conservative emergency-management language, but they should not be converted into a routine consumer rule for scheduling nitrates around tadalafil.
| Time after last tadalafil dose in the study | Nitroglycerin interaction result |
|---|---|
| 2 hours | Significant interaction observed |
| 4 hours | Significant interaction observed |
| 8 hours | Significant interaction observed |
| 24 hours | Significant interaction observed |
| 48 hours | Not observed by most hemodynamic measures, but greater BP lowering still occurred in a few more tadalafil subjects than placebo |
| 72 hours | Interaction not detectable |
| 96 hours | Interaction not detectable |
Current CIALIS labeling contains a narrow provision for a patient who has already taken tadalafil and then develops a life-threatening situation in which nitrate administration is considered medically necessary. In that circumstance, the label states that at least 48 hours should elapse after the last tadalafil dose before nitrate administration is considered.
The same labeling immediately adds that nitrates should still be administered only under close medical supervision with appropriate hemodynamic monitoring. The 48-hour statement therefore describes emergency clinician-directed management; it does not cancel the routine contraindication.
It should not be interpreted as permission for a patient to plan nitrate use independently after counting 48 hours.
| Interpretation of 48 hours | Correct? |
|---|---|
| Routine tadalafil and nitrate use becomes acceptable after a self-selected 48-hour interval | No |
| The wording applies to a life-threatening situation where nitrate therapy is medically necessary | Yes |
| At least 48 hours should have elapsed before nitrate administration is considered in that circumstance | Yes |
| Medical supervision and hemodynamic monitoring are still required | Yes |
| The underlying nitrate contraindication disappears | No |
Tadalafil has a mean terminal half-life of approximately 17.5 hours in healthy subjects. Its concentration therefore declines gradually rather than disappearing shortly after a dose, helping explain why interaction considerations extend well beyond the first few hours.
The half-life provides pharmacokinetic context, but the nitrate guidance should not be reconstructed by simply multiplying 17.5 hours by a chosen number of half-lives. The 48-hour emergency language is supported by direct nitroglycerin interaction data and regulatory interpretation, not by a simple mathematical half-life rule.
The PK meaning of 17.5 hours is covered separately on the tadalafil half-life page.
| Concept | Meaning |
|---|---|
| Mean terminal tadalafil half-life | Approximately 17.5 hours in healthy subjects |
| Does tadalafil disappear after one half-life? | No |
| Can the nitrate rule be derived from half-life alone? | No |
| Best basis for the label timing context | Direct clinical pharmacology interaction study plus current labeling |
Current CIALIS patient information states that after a single tablet, some active ingredient remains in the body for more than 2 days. It also notes that tadalafil may remain longer in people with kidney or liver problems or when certain other medications are used.
This patient-facing statement reinforces why a short interval after tadalafil should not be assumed to eliminate interaction potential. It also shows why a generic one-size-fits-all timing calculation based only on the clock can be misleading.
Organ-function effects on tadalafil exposure are addressed in more detail on the renal impairment and hepatic impairment pages.
| Factor | Potential relevance |
|---|---|
| Single tadalafil tablet | Some active ingredient remains for more than 2 days |
| Kidney impairment | Can prolong or increase tadalafil exposure |
| Liver impairment | Can change tadalafil handling and labeled use |
| Certain interacting medicines | Can increase tadalafil exposure |
Once-daily tadalafil produces continuous plasma exposure. Current labeling specifically calls attention to ongoing interaction potential when tadalafil is prescribed every day.
The nitrate contraindication remains in place for daily treatment just as it does for as-needed treatment. A lower daily tablet strength should not be interpreted as eliminating the pharmacodynamic interaction.
The exposure pattern of repeated dosing is covered on the daily tadalafil page.
| Tadalafil regimen | Organic nitrate status |
|---|---|
| As-needed use | Contraindicated with organic nitrates |
| Once-daily use | Contraindicated with organic nitrates |
| Lower tadalafil strength | Does not remove the formal nitrate contraindication |
Current CIALIS patient counseling warns that taking tadalafil with nitrates can cause blood pressure to fall suddenly to an unsafe level. The label specifically mentions dizziness, syncope and potentially serious cardiovascular consequences.
This is different from tadalafil's modest average blood-pressure effect when studied alone in healthy subjects. The interaction matters because nitrate-mediated vasodilation can be amplified by PDE5 inhibition.
For tadalafil's broader blood-pressure pharmacology outside the nitrate contraindication, see the tadalafil blood-pressure guide.
| Potential consequence mentioned in patient counseling | Clinical context |
|---|---|
| Dizziness | Possible consequence of unsafe blood-pressure lowering |
| Syncope / fainting | Possible consequence of marked hypotension |
| Serious cardiovascular event | Patient counseling warns of potentially severe consequences when BP falls to an unsafe level |
CIALIS patient counseling specifically addresses the possibility of anginal chest pain after tadalafil use. Patients who experience anginal chest pain after taking CIALIS are instructed to seek immediate medical attention rather than independently using a nitrate according to a self-calculated interval.
The label also emphasizes that emergency healthcare professionals should know when tadalafil was last taken. That timing information matters because clinicians may need to evaluate both the nitrate contraindication and alternative management options.
This page does not provide individualized emergency-medication instructions beyond the current label because nitrate decisions in this setting require medical supervision.
| Situation | Label-supported response |
|---|---|
| Anginal chest pain after tadalafil | Seek immediate medical attention |
| Emergency healthcare encounter | Healthcare professionals should be told when tadalafil was last taken |
| Self-directed nitrate use | Not supported by the CIALIS counseling framework |
Tadalafil can interact with several medicines that lower blood pressure, but their regulatory categories differ. Alpha-blockers and antihypertensives generally appear under caution or additive blood-pressure-effect guidance, whereas organic nitrates are formally contraindicated.
The difference is important because a user should not infer that a tolerated combination with one blood-pressure medicine means nitrates are also acceptable. Interaction management is specific to the drug class and mechanism.
The complete hierarchy is summarized on the drug-interactions page.
| Drug class | Tadalafil interaction category |
|---|---|
| Organic nitrates | Contraindicated |
| Alpha-blockers | Caution / indication-specific not-recommended framework |
| Other antihypertensives | Potential additive blood-pressure lowering |
| GC stimulators such as riociguat | Separate formal contraindication |
Organic nitrates and guanylate cyclase stimulators such as riociguat are both contraindicated with tadalafil because of excessive hypotensive potential, but they are different pharmacologic classes. Nitrates act through nitric oxide-related signaling, while riociguat directly stimulates soluble guanylate cyclase and also sensitizes it to nitric oxide.
The two categories should therefore remain separate within the safety architecture. A nitrate-specific page should not become a duplicate of the riociguat interaction page merely because both ultimately affect cGMP and blood pressure.
The GC-stimulator mechanism is covered on the tadalafil and riociguat page.
| Interaction | Drug class | Tadalafil status |
|---|---|---|
| Organic nitrates | NO-donor / nitrate therapy | Contraindicated |
| Riociguat | Guanylate cyclase stimulator | Contraindicated |
Several common interpretations weaken or distort the actual label. The nitrate contraindication does not apply only to high tadalafil doses, daily nitrate users or one particular nitroglycerin formulation.
Likewise, the 48-hour emergency language is not a general permission rule, and tadalafil's 17.5-hour half-life should not be used to create a personal nitrate schedule. The clinical pharmacology study and current labeling provide the relevant evidence framework.
Keeping these distinctions explicit is especially important because nitrates may be used intermittently, meaning a person may not think of them as part of a routine medication list.
| Misunderstanding | Correct interpretation |
|---|---|
| Only daily nitrates are contraindicated | Regular and intermittent organic nitrate use are both contraindicated |
| Only nitroglycerin tablets matter | The contraindication covers any form of organic nitrate |
| A low tadalafil dose removes the interaction | No |
| 48 hours is a routine self-directed scheduling rule | No; the label uses it in a life-threatening clinician-directed context |
| The 48-hour framework comes only from multiplying tadalafil's half-life | No; direct nitroglycerin interaction data support the timing context |
A safe interaction review starts by identifying nitrate exposure before focusing on dose timing. Prescription nitrates, intermittent angina treatment and relevant recreational substances can all be missed if the review is limited to medicines taken every day.
The key distinction is whether an organic nitrate is involved at all; routine tadalafil use with that nitrate is contraindicated under current U.S. labeling.
| Check | Question |
|---|---|
| Medication identity | Is nitroglycerin, isosorbide dinitrate, isosorbide mononitrate or another organic nitrate being used? |
| Frequency | Is nitrate use intermittent as well as regular? |
| Dosage form | Could the nitrate be a spray, patch, ointment, paste or tablet? |
| Recreational exposure | Are nitrate/nitrite-containing 'poppers' relevant? |
| Tadalafil regimen | Is tadalafil used as needed or daily? The nitrate contraindication applies to both frameworks |
| Emergency context | If urgent cardiac care is needed, do healthcare professionals know when tadalafil was last taken? |
Tadalafil is contraindicated with any form of organic nitrate, whether nitrate use is regular or intermittent. The interaction is pharmacodynamic: overlapping NO-cGMP signaling can produce excessive vasodilation and potentially unsafe blood-pressure lowering.
Controlled clinical pharmacology data provide direct timing evidence. In the label-described nitroglycerin study, a significant interaction was observed through 24 hours; at 48 hours it was absent by most hemodynamic measures although some greater blood-pressure lowering remained in a few more tadalafil-treated participants, and after 48 hours the interaction was not detectable.
The label's at-least-48-hour language applies only when nitrate therapy is considered medically necessary in a life-threatening situation and still requires close medical supervision and hemodynamic monitoring. It does not replace the routine contraindication or provide a self-directed nitrate schedule.
No routine concomitant use is permitted under current U.S. CIALIS labeling. Tadalafil is contraindicated in patients using any form of organic nitrate, whether nitrate use is regular or intermittent.
Tadalafil inhibits PDE5 and increases cGMP signaling, while organic nitrates increase nitric oxide-driven cGMP formation. Combining the effects can produce excessive vasodilation and potentially unsafe blood-pressure lowering.
Routine combined use is contraindicated. Nitroglycerin is an organic nitrate, and current CIALIS labeling states that tadalafil potentiates the hypotensive effect of nitrates.
Yes. Current labeling explicitly applies the contraindication to organic nitrate use whether it is regular or intermittent.
Current CIALIS patient information specifically mentions nitroglycerin, isosorbide dinitrate and isosorbide mononitrate. Other organic nitrates also fall under the formal contraindication.
Yes. CIALIS patient information specifically notes nitroglycerin in forms including tablets, sprays, ointments, pastes and patches. The contraindication is not limited to one nitroglycerin formulation.
Current CIALIS patient information warns against recreational 'poppers' containing nitrates or nitrites such as amyl nitrite or butyl nitrite because they can create the same dangerous vasodilatory interaction context.
In the clinical pharmacology study described in current CIALIS labeling, a significant tadalafil–nitroglycerin interaction was observed at every tested timepoint through 24 hours. At 48 hours it was no longer seen by most hemodynamic measures, although greater blood-pressure lowering still occurred in a few more tadalafil-treated subjects; after 48 hours the interaction was not detectable.
The 48-hour language applies to a life-threatening situation in which nitrate administration is considered medically necessary after tadalafil. Current labeling states that at least 48 hours should have elapsed before nitrate administration is considered, and nitrates should still be given only under close medical supervision with appropriate hemodynamic monitoring.
No. The current CIALIS label continues to classify routine concomitant nitrate use as contraindicated. The 48-hour statement is narrow emergency medical guidance, not a general self-directed permission rule.
Tadalafil declines gradually because its mean terminal half-life is about 17.5 hours in healthy subjects, so meaningful drug exposure can persist well beyond the first several hours. However, nitrate timing guidance should be based on current labeling and direct interaction evidence rather than calculated from half-life alone.
No. Current labeling bases the interaction context on a controlled nitroglycerin study as well as tadalafil pharmacology. The 48-hour emergency language should not be reconstructed from a simple half-life calculation.
The label describes a double-blind, placebo-controlled crossover study in 150 men aged at least 40 years. Participants received tadalafil 20 mg daily or placebo for 7 days, followed by 0.4 mg sublingual nitroglycerin at prespecified times after the final dose.
The current CIALIS label reports nitroglycerin testing at 2, 4, 8, 24, 48, 72 and 96 hours after the last dose of tadalafil in the dedicated interaction study.
Yes. A significant interaction was observed at each tested timepoint through and including 24 hours in the current label-described study.
At 48 hours, the interaction was not observed by most hemodynamic measures, although a few more tadalafil-treated subjects than placebo-treated subjects experienced greater blood-pressure lowering. The label still uses an at-least-48-hour threshold only within its medically necessary life-threatening emergency framework.
No. Once-daily tadalafil creates continuous plasma exposure, but organic nitrate use remains contraindicated. A lower daily tadalafil strength does not create a nitrate exception.
Yes. The formal nitrate contraindication applies to tadalafil use generally; it is not limited to 10 mg or 20 mg tablets.
Current CIALIS counseling instructs patients who experience anginal chest pain after taking the drug to seek immediate medical attention. Emergency healthcare professionals should be told when tadalafil was last taken so they can manage the interaction context appropriately.
No. Both are contraindicated with tadalafil because of hypotensive potential, but they are different drug classes. Organic nitrates act through nitric oxide-related signaling, while riociguat is a guanylate cyclase stimulator with its own interaction mechanism.